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ABSTRACT: Civet, the perineal gland secretion of Malabar Civet cat (Moschothera civettina 
blyth) in doses ranging from 100 to 800 mg/kg p.o. produced significant potentiation of 
pentobarbitone induced hypnosis, mild analgesis and anticonvulsant activities.  However, it is 
devoid of hypothermic effect in mice and antipyretic activity in febrile rats.  It also failed to 
produce any effect in the “rota – rod test”, to influence the amphetamine toxicity in aggregated 
mice and in the conditioned avoidance response in trained rats.  In the acute toxicity studies 
civet was found to be devoid of any toxic manifestations or mortality in mice upto a dose of 800 
mg/kg orally.  
 
INTRODUCTION 
 
Civet is the glandular secretion of civet cats 
(Family : Viverridae), the perineal glands of 
which open beneath the base of its tail in to  
a large pouch in which a “honey like” 
secretion accumulates, which when fresh in 
pale yellow in colour, but becomes viscous 
black waxy mass with an unimaginable 
obnoxious stink.  Still civet is an 
irreplaceable essential substance as fixative 
for the most expensive perfumes, giving 
them life and lift.   Besides its invaluable use 
in the perfume industry it has been attributed 
with certain medicinal properties also.  A 
survey of the ayurvedic literature reveals 
that civet when applied externally removes 
localized pains and itching sensations and is 
useful in scabies, pimples and other skin 
infections.  Internally it is useful in mental 
retardation, insanity, fainting and 
convulsions.  It is also useful in colic pains, 
asthma, cough and other respiratory 
troubles.  It removes palpitation of heart and 
is used in cardiac weakness
1,2.  But no 
systematic pharmacological study has been 
undertaken to explore its therapeutic 
potentialities.  Hence it was thought worth 
while to carry out the  pharmacological 
screening of civet in detail and the preset 
work deals with its actions on the Central 
Nervous System. 
 
MATERIALS AND METHODS 
 
The material for the present study was a 
pooled sample of civet collected  throughout 
the year from the male species of Malabar 
civet cat (Moschothera civettina Blyth) kept 
in captivity in the animal house of the 
Medical Collect, Trivandrum. 
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Preparation of the test drug: 
 
Unless otherwise stated, for all these 
experiments, weighed quantity of the civet 
sample was  thoroughly mixed with warm 
3% Tween – 80 solutions (aqueous) to form 
a fine suspension. 
 
Albino mice of Swiss strain (25 to 35 gms) 
and albino rats of Holtzman strain (100 to 
150g) of either sex were used for all these 
experiments unless mentioned otherwise. 
 
a)  Acute toxicity studies : 
 
Graded doses of civet (100 mg, 200mg, 400 
mg and 800 mg/kg) was administered orally 
to groups of 10 mice each.  Another group 
serving as vehicle control received 3% 
Tween – 80 solution orally.  These animals 
were watched at intervals of 30 min up to 4h 
and then after 24h, 48h, 72h and finally after 
one week for any toxic manifestations or 
mortality. 
 
b)  Effect on behavioural pattern: 
 
The behavioural effects were studied after 
oral administration of civet in the above 
doses with the same vehicle control using 10 
mice in each group. 
 
c)  Potentiation of pentobarbital induced 
hypnosis: 
 
Aqueous solution of phentobarbital sodium 
(40 mg/kg) was injected intraperitoneally to 
groups of 20 mice each, 30 min after oral 
administration of civet (25 mg, 50 mg, 
100mg, and 200mg/kg) or 3% Tween – 80 
solution or water.  The period between the 
loss and return of righting reflex was taken 
as sleeping time.  This experiment was 
performed at a room temperature of 27
oC. 
 
d)  Analgesic effect: 
 
I.  Tail flick method: 
 
Analgesic activity was tested by using 
albino rats by the Tail flick method.  The tail 
of the animal was kept overran electrically 
heated nichrome wire of the Analgesiometer 
(Techno model).  The animal was presumed 
to have felt pain when there occurred a 
sudden and characterstic flick of the tail.   
The analgesic activity was evaluated in 
terms of alterations in the reaction time.   
The reaction time was recorded for each 
animal once before oral administration of 
civet (25mg, 50mg, 100mg, and 200mg/kg) 
or 3% Tween 80 solution and then every 30 
min. for 2h after test drug administration.   
Groups of 8 animals were employed for 
each dose and one group received Pethidine 
and Hcl (25 mg/kg) orally which served as 
the reference standard. 
 
II.  Acetic acid induced writhing test: 
 
The method employed was that of Witkin at 
al3.  Male albino mice were made to writhe 
by an intraperitoneal injection of 300 mg/kg 
of 3%  v/v aqueous acetic acid.  Civet 
(100mg, 20mg and 400mg/kg) and 3% 
Tween  –  80 solution were given orally 
30min prior to the administration of acetic 
acid.  Groups of 10 mice were employed.   
Each mouse was put in a circular glass 
through (100 x 190 mm) and the total 
number of stretching episodes for 30 min 
were recorded.  Acetyl salicyclic acid (100 
mg/kg) was administrated orally to one 
group of animals which served as the 
reference standard.  Effect of the test drug 
was evaluated by the decrease in the number 
of stretching episodes over that of the 
vehicle control group. 
 
e)  Hypothermic effect: 
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Albino mice were employed for this 
experiment.  Civet (100 mg, 200 mg and 400 
mg/kg or 3% Tween –  80 solution or 
chlorpromazine Hcl (2.5 mg/kg) were 
administered orally to groups of six animals.  
Rectal temperature of these animals were 
recorded before and then at every 30min for 
2h and then at 3h and 4h after the 
administration of drugs or solvent.  These 
experiments were conducted at a room 
temperature of 27
oC. 
 
In another set of experiments, the effect of 
civet on chlorpromazine induced 
hypothermia in mice was studied.  Civet 
(100 mg/kg) was administered orally to mice 
30 min after the administration of 
chlorpormazien (2.5 mg/kg p.o).  Rectal 
temperature of these animals were noted as 
in the previous experiment. 
 
f)  Antipyretic effect: 
 
Albino rats were made febrile by a sub 
cutaneous injection of 15% brewers yeast in 
2% gum acacia in normal saline.  Those rats 
which showed a rise of atleast 2
oF from the 
normal temperature before yeast injection 
were only selected for drug testing.  They 
were divided into groups of 6 animals each.  
Civet in doses of 200 mg and 400 mg/kg 
were administered orally to the first two 
groups.  Next three groups received water, 
3% Tween – 80 solution and acetyl salicylic 
acid (100 mg/ kg orally).  Rectal 
temperature was recorded initially and at 30 
min interval for the first 2hr and thereafter at 
1h interval for 2 more hours after drug 
treatment.  Results were analysed using 
students ‘t’ test. 
 
g)  Anticonvulsant effect: 
 
I.  Electroconvulsions: 
 
This was studied in albino rats by the 
supramaximal electroshock seizure pattern 
test using Techno model convulsiometer 
according to the method of Holland et a
l4.  
The electroshock (150 mA for a duration of 
0.2 secs) was delivered through ear 
electrodes and the duration of tonic extensor 
phase was recorded.  Civet (100mg, 200mg, 
400mg and 800mg/kg) was administered 
orally to these animals one hour before they 
were subjected to electro shock.  One group 
of animals received 3% Tween 80 solution 
while another group received Dilantin 
sodium (20mg/kg) orally which served as 
reference standard.  Prevention or reduction 
in the duration of tonic extensor phase was 
taken as the criteria for anticonvulsant. 
 
II.  Metrazol induced seizures: 
 
Anticonvulsant activity was determined by 
the method of Swinyard et al
5.  Civet 
(100mg, 200mg and 400mg/kg) was 
administered to different groups of mice one 
hour before the subcutaneous injection of 
metrazol (100mg/kg).  One group received 
phenobarbitone sodium (25mg/kg) orally 
while another group received 3% Tween – 
80 solution which served as the vehicle 
control.  The number of animals protected in 
each group was recorded and anticonvulsant 
activity was represented as percent 
protection. 
 
h)  Effect  on conditional avoidance 
response (CAR) and Escape response 
(E. R.) in trained rats: 
The method employed was similar to that of 
Cook and Weidley
6  with minor 
modifications using male albino rats.  Two 
types of responses were studied conditioned 
avoidance response in which the animal 
climbed the pole of hearing the buzzer and 
the escape response in which the animals 
escaped by climbing the pole only after 
receiving the shock.  The animals were Pages 232- 239 
divided into six groups.  Civet (50mg, 
100mg, and 200mg and 400mg/kg), was 
administered orally to the first four groups, 
while the fifth and sixth group received 
chlorpromazine.  Hcl (5mg/kg and 3% 
Tween  –  80 solution orally respectively.   
They were examined before and at intervals 
of 30 min after the administration of test 
drugs for the first 2h and then at intervals of 
1h for the next 3h for the exhibition of the 
above two responses. 
 
The same study was extended to find out the 
effect of civet (200mg and 400mg/kg) on 
chlorpromazine treated (5mg/kg orally) 
trained rats in blocking the conditioned 
avoidance response by administering orally 
30 min after oral administration of 
chlorpromazine.  Other experimental details 
were same as in the above case. 
 
i)  Effect on “rota – rod test”: 
 
This was performed according to the method 
of Janssen et al7.  Albino mice were placed 
on a horizontal rotating road having a 
diameter of 32mm and rotating at the rate of 
5 revolutions per minute.  Animals which 
remained on the rod for 3 or more minutes 
in two successive trials were selected and 
placed in groups of five.  Civet in doses of 
100, 200, 400 and 800 mg/kg were 
administered to different groups and they 
were placed on the rod at intervals of 30, 60, 
90, 120 and 150 min after drug 
administration. If an animal failed more than 
once to remain on the rod for 3 min the test 
was considered positive, that is producing 
motor inco-ordination.  
 
j)  Effect on amphetamine toxicity in 
aggregated mice: 
 
This was studied by the method suggested 
by Burn and Hobbs
8.  Amphetamine sulfate 
solution (14 mg/kg) was administered 
subcutaneously to make mice one hour 
before oral administration of civet.  (100, 
200, 400 and 800mg/kg).  Control group 
received 3% Tween 80 solution apart from 
amphetamine sulfate.  Experimental was 
carried out at 27.5
oC and the percentage 
mortality in each group noted. 
 
RESULTS 
 
a)  Acute toxicity studies: 
 
Civet when administered orally in doses of 
100mg, 200mg, 400mg and 800mg/kg 
neither produced any toxic manifestations 
nor mortality in albino mice up to a period 
of one week.  Its LD50 could not be found 
out since even in the 800 mg/kg dose there 
was no mortality and the preparation of the 
test drug in higher concentration was 
difficult. 
 
b)  Effect on behavioural pattern: 
 
Signs of increasing CNS  depression was 
observed in animals treated with 200mg, 
400mg and 800 mg/kg of civet orally as 
evidenced by increased sedation, ptosis and 
decreased motility.  No such effect was 
observed in control animals treated with the 
solvent (3% tween –  80 solution) in the 
same quantity. 
 
c)  Potentiation of pentobarbital induced 
hypnosis: 
 
Three percent Tween – 80 solutions as well 
as civet in doses of 25 mg/kg and 50 mg/kg 
orally failed to produce any significant 
change in the Pentobarbital (40mg/kg i.p) 
induced hypnosis.  But in higher doses 
(100mg and 200mg/kg orally) civet 
potentiated this action significantly (Table 
I). 
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TABLE – I 
 
Effect of Civet on Hypnosis due to Pentobarbital (40 mg/kg) in Albino Mice 
 
Group  Drug with dose (mg/kg)  Mean sleeping time 
(min) ± S. E. (using 20 
mice in each group) 
P 
I 
 
 
II 
 
 
III 
 
 
IV 
 
 
V 
 
 
VI 
 
Water + Pentobarbital (40) 
 
 
3% Tween – 80 + Pentobarbital (40) 
 
 
Civet (25) + Pentobarbital (40) 
 
 
Civet (50) + Pentobarbital (40) 
 
 
Civet (100) + Pentobarbital (40) 
 
 
Civet (200) + Pentobarbital (40) 
50.5 ± 1.82 
 
 
52.4 ± 3.63 
 
 
56.85 ± 2.94 
 
 
60.8 ± 3.14 
 
 
69.3 ± 5.0 
 
 
84.75 ± 5.03 
- 
 
 
N. S. 
 
 
N.S. 
 
 
N. S. 
 
 
<0.02 
 
 
<0.01 
 
 
Group II was compared with group I and groups III, IV, V and VI were compared with group II 
for statistical significance. 
 
N. S. : Not significant 
 
d)  Analgesic effect 
 
I.  Tail flick method: 
 
Civet in doses of 25 mg and 50mg/kg orally 
failed to produced any analgesic effect in 
rats when treated by this method.  But in 
higher doses (100 mg and 200 mg/kg p.o) 
mild analgesic activity was exhibited by this 
drug as evidenced by a significant increase 
in the reaction time.  Maximum activity was 
noted 60 min after oral administration of the 
test drug (Table II). 
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TABLE – II 
 
Analgesic Effect of Civet as Tested by Tail Flick Method in Rats 
 
Group  Drug with 
dose (mg/kg) 
Reaction time in seconds 
    Before drug 
administration 
After 30 min  After 60 min  After 90 min  After 120 min 
I 
 
II 
 
III 
 
IV 
 
 
V 
 
 
VI 
3% Tween -80 
 
Civet (25) 
 
Civet (50) 
 
Civet (100) 
 
 
Civet (200 
 
 
Pethidine Hcl 
(25) 
5.56 ± 0.33 
 
6.48 ± 0.39 
 
6.29 ± 0.50 
 
6.08 ± 0.27 
 
 
6.30 ± 0.14 
 
 
6.11 ± 0.31 
5.9 ± 0.17 
 
6.55 ±  0.30 
 
6.58 ± 0.53 
 
6.99 ± 0.22  
P<0.02 
 
7.08 ± 0.31 
P < 0.05 
 
10.26 ± 0.37  
P<0.01 
 
6.11 ± 0.28 
 
6.76 ± 0.32 
 
6.79 ± 0.42 
 
7.43 ± 0.20 
P<0.01 
 
7.76 ± 0.37 
P<0.01 
 
10.01 ± 0.30 
P<0.01 
5.85 ± 0.26 
 
6.80 ± 0.29 
 
6.6 ± 0.40 
 
7.2  ± 0.25 
P<0.02 
 
7.26 ± 0.27 
P<0.01 
 
8.61 ± 0.32 
P<0.01 
5.71 ± 0.21 
 
6.59 ± 0.26 
 
6.36 ± 0.41 
 
6.48 ± 0.30 
N. S 
 
6.8 ± 0.26 
N. S 
 
7.36 ± 0.33 
P<0.02 
 
Reaction times after drug administration at intervals of 30 min, 60 min, 90 min and 120 min 
were compared with that before drug administration in each group. 
 
N. S. : Not significant. 
 
II.  Acetic acid induced writhing test: 
 
In acetic acid induced writhing test civet in 
doses of 200 mg and 400mg/kg  orally 
showed significant analgesic activity.  The 
activity produced by 400 mg/kg was 
comparable to that of acetylsalisylic acid 
(100 mg/kg p.o). (Table III). 
 
TABLE – III 
 
Analgesic activity of Civet – Acetic acid induced Writhing in Mice. 
 
Group  Drug with dose (mg/kg 
p.o) 
Number of mice 
used 
Number of writhing in 
30 min after treatment 
(mean ± S. E.) 
P 
I 
 
II 
 
Water 
 
3% Tween – 80 solution  
 
10 
 
10 
 
46.1 ± 3.64 
 
43.7 ± 2.89 
 
- 
 
N.S 
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    III 
 
IV 
 
V 
 
VI 
 
Civet (100) 
 
Civet (200) 
 
Civet (400) 
 
Acetyl salicylic acid 
(100 
 
10 
 
10 
 
10 
 
10 
 
37.4 ± 2.87 
 
28.8 ± 4.49 
 
19.8 ± 2.04 
 
17.6 ± 2.95 
 
N.S 
 
<0.05 
 
<0.001 
 
<0.001 
 
Group II was compared with group I and groups III, IV, V and VI were compared with group 
II for statistical significance. 
 
N. S. : Not significant 
 
e)  Hypothermic action 
 
Civet in doses of 200mg and 400mg/kg 
orally produced no significant hypothermic 
effect in normal mice.  Moreover it failed to 
influence the hypothermic effect produced 
by chlorpromazine (2.5 mg / kg p.o) in a 
dose of 100 mg/kg orally. 
 
f)  Antipyretic effect 
 
Civet in doses of 200 mg and 400 mg/kg 
failed to exhibit any antipyretic effect in 
febrile rats. 
 
g)  Anticonvulsant effect: 
 
I.  Electroconvulsions: 
 
Civet in does of 200mg, 400 mg and 
800mg/kg (p.o) was found to produce 
significant anticonvulsant effect in rats 
subjected to Maximal Electroshock seizures 
(MES).  Vehicle control (3% Tween –  80 
solution) as well as civet in a lower dose 
(100mg/kg) failed to produce this effect 
(Table IV). 
 
TABLE – IV 
 
Effect of Civet on Electro convulsions in rats 
 
Group  Drug with dose (mg/kg)  Number of 
rats used 
Number of 
rats showing 
tonic 
extensor 
spasm 
Mean duration 
of tonic 
extensor spasm 
(secs). ± S. E. 
P 
I 
 
II 
 
III 
 
Water 
 
3% Tween – 80 solution 
 
Civet (100) 
 
10 
 
10 
 
10 
 
10 
 
10 
 
10 
 
11.53 ± 0.63 
 
11.18 ± 0.51 
 
9.78 ± 0.52 
 
- 
 
N. S. 
 
N. S. 
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IV 
 
V 
 
VI 
 
VII 
 
Civet (200) 
 
Civet (400) 
 
Civet (800) 
 
Dilantin solution (20) 
10 
 
10 
 
10 
 
10 
10 
 
10 
 
10 
 
8 
8.72 ± 0.63 
 
7.45 ± 0.46 
 
6.03 ± 0.44 
 
4.20 ± 0.75 
<0.01 
 
<0.001 
 
<0.001 
 
<0.001 
 
Group III was compared with group I and groups III, IV, V, IV and VII were compared with 
group II for statistical significance. 
 
N. S. : Not Significant. 
 
II.  Metrazol induced convulsions: 
 
In metrazol induced convulsions the 
percentage protection afforded by civet in 
doses of 100mg, 200mg and 400mg/kg 
orally was found to be 10%, 40% and 40% 
respectively.  Phenobarbitone (25mg/kg) 
produced 40% protection while 3% Tween – 
80 solution failed to produce any protection 
in these animals (Table V). 
 
TABLE –V 
 
Influence of Civet on Metrazol induced convulsion in Mice. 
 
Group  Drug with dose (mg/kg)  Number of animals 
used 
Percentage 
protection afforded 
by the drug 
I 
 
II 
 
III 
 
IV 
 
V 
 
VI 
Water + metrazol (100) 
 
3% Tween – 80 + metrazol (100) 
 
Civet (100) + metrazol (100) 
 
Civet (200) + metrazol (100) 
 
Civet (400) + metrazol (100) 
 
Phenobarbitone sodium (25)  + 
metrazol (100) 
 
10 
 
10 
 
10 
 
10 
 
10 
 
10 
- 
 
- 
 
10 
 
40 
 
40 
 
40 
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h)  Effect on conditional avoidance response and escape response. 
 
Civet in doses of 50mg, 100mg, 200mg and 
400mg/kg orally caused no loss of 
conditioned avoidance behaviour and no 
change in the escape phenomenon.  It also 
failed to influence the blockade of CAR 
induced by chlorpromazine (5mg / kg p.o.) 
 
i)  Effect on “rota – rod” test: 
 
Civet in does of 100, 200, 400 and 
800mg/kg failed to produce any effect on 
the “rota-rod” test. 
 
j)  Effect on amphetamine toxicity in 
aggregated mice: 
 
Civet in doses of 100, 200, 400 and 
800mg/kg failed to influence the 
amphetamine toxicity in aggregated mice. 
 
DISCUSSION 
 
The present investigation has shown that 
civet in varying doses increased CNS 
depression (as evidenced by sedation, ptosis 
and lesser motility), produced analgesic 
activity,  potentiated pentobarbitone sodium 
induced hypnosis and exhibited 
anticonvulsant activity.  But it failed to 
produce hypothermia in mice and antipyretic 
effect in febrile rats.  It also failed to block 
“Conditioned avoidance response” in trained 
rats and did not influence chlorpromazine 
induced blockage of “CAR”.  In “Rota-rod 
test” civet did not produce motor inco-
ordination in mice.  It also failed to 
influence amphetamine toxicity in 
aggregated mice.  In acute toxicity studies 
civet upto a dose of 800 mg/kg orally was 
found to be non toxic.  Its LD50 could not be 
found out since even with the dose of 800 
mg/kg there was no mortality and the 
preparation of higher concentration of this 
drug was difficult.  From these observations 
it is presumed that the effect of civet on the 
central nervous system is more or less like 
that of a barbiturate rather than a 
tranquilliser.  However the Ayurvedic use of 
civet in insanity can be partially attributed to 
its sedative properties.  Normally 
tranquillisers block conditioned avoidance 
response in trained rats, produce 
hypothermia and motor inco –  ordination 
and decrease amphetamine toxicity in 
aggregated mice.  But civet failed to exhibit 
these effects even thought it produced lesser 
motility and potentiated pentobarbitone 
induced hypnosis similar to tranquillisers.   
The anticonvulsant property exhibited by 
civet gives more support for this conclusion.  
The substances which depresses Central 
Nervous System have a variety of 
manifestations.  Since the mildest of these is 
tranquillisation the tests for tranquillising 
agents and some of the Central Nervous 
System depressants overlap.  Hence more 
work has to be done in order to confirm its 
mechanism of action. 
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